Antibodies, Antiphospholipid
"Antibodies, Antiphospholipid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Autoantibodies directed against phospholipids. These antibodies are characteristically found in patients with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC;), ANTIPHOSPHOLIPID SYNDROME; related autoimmune diseases, some non-autoimmune diseases, and also in healthy individuals.
MeSH Number(s)
D12.776.124.486.485.114.323.210
D12.776.124.790.651.114.323.210
D12.776.377.715.548.114.323.210
Below are MeSH descriptors whose meaning is more general than "Antibodies, Antiphospholipid".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Antiphospholipid".
This graph shows the total number of publications written about "Antibodies, Antiphospholipid" by people in Harvard Catalyst Profiles by year, and whether "Antibodies, Antiphospholipid" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 0 | 1 | 1 |
| 1993 | 0 | 1 | 1 |
| 1994 | 1 | 0 | 1 |
| 1995 | 0 | 1 | 1 |
| 1996 | 3 | 1 | 4 |
| 1998 | 4 | 0 | 4 |
| 1999 | 1 | 1 | 2 |
| 2000 | 2 | 0 | 2 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 2 | 0 | 2 |
| 2007 | 1 | 1 | 2 |
| 2008 | 0 | 4 | 4 |
| 2009 | 2 | 2 | 4 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 3 | 0 | 3 |
| 2015 | 2 | 1 | 3 |
| 2016 | 2 | 1 | 3 |
| 2017 | 2 | 2 | 4 |
| 2018 | 2 | 1 | 3 |
| 2019 | 2 | 2 | 4 |
| 2020 | 1 | 0 | 1 |
Below are the most recent publications written about "Antibodies, Antiphospholipid" by people in Profiles.
-
Impaired B cell anergy is not sufficient to breach tolerance to nuclear antigen in V?8/3H9 lupus-prone mice. PLoS One. 2020; 15(7):e0236664.
-
Membranous Nephropathy Posttransplantation: An Update of the Pathophysiology and Management. Transplantation. 2019 10; 103(10):1990-2002.
-
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019 09; 71(9):1400-1412.
-
Antiphospholipid score is a novel risk factor for idiopathic osteonecrosis of the femoral head in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2019 04 01; 58(4):645-649.
-
Circulating plasmablasts contribute to antiphospholipid antibody production, associated with type I interferon upregulation. J Thromb Haemost. 2019 07; 17(7):1134-1143.
-
Clinical profiles and risk assessment in patients with antiphospholipid antibodies. Expert Rev Clin Immunol. 2019 01; 15(1):73-81.
-
Systemic lupus erythematosus and systemic sclerosis: All roads lead to platelets. Autoimmun Rev. 2018 Jun; 17(6):625-635.
-
Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism. Blood. 2018 05 10; 131(19):2151-2160.
-
CD39 and CD73 activity are protective in a mouse model of antiphospholipid antibody-induced miscarriages. J Autoimmun. 2018 03; 88:131-138.
-
Q10uest for New Therapies to Prevent Antiphospholipid Antibody-Mediated Thrombosis. Arterioscler Thromb Vasc Biol. 2017 10; 37(10):1801-1802.